Inhibitory effect of isorhamnetin and hesperidin on the oxidation of high-density lipoproteins (HDL) induced by Cu2+

Journal of Sichuan University (Medical Science)

Volumn 38, Issue 6, 2007, Pages 961-964

  Liu, Rui ^a   Meng, Fang ^a   Bai, Huai ^a   Liu, Yu ^a   Liu, Bing Wen ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Antioxidation; Hesperidin; High density lipoprotein; Isorhamnetin; Oxidized modification

Indexed keywords

EID: 36549039992     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Nofer JR, Kehrel B, Fobker M, et al. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis, 2002 ; 161 (1) : 1-16.
2. Callegari E, Norata GD, Inoue H, et al. Oxidized-HDL3 modulates the expression of Cox-2 in human endothelial cells. Int J Mol Med, 2006 ;18 (1) : 209-213.
3. Chinese source
4. Chinese source
5. Chinese source
6. Miwa Y, Mitsuzumi H, Sunayama T, et al. Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality. J Nutr Sci Vitaminol (Tokyo), 2005 ; 51 (6) : 460-470.
7. Wang ZR, Wang L, Yin HH, et al. Effect of total flavonoids of hippophae rhamnoides on contractile mechanics and calcium transfer in stretched myocyte. 2000 ; 13 (1) : 6-9.
8. Chinese source
9. McElveen J, Mackness MI, Colley CM, et al. Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction. Clin Chem, 1986 ; 32 (4) : 671-673.
10. Chinese source
11. Liu BW, Jiang Y, Fu MD, et al. Oxidative modification of lipoproteins in hypertriglyceridemic patients and hypercholesterolemic rabbits in vivo. Mol Cell Biochem, 2000 ; 207 (1-2) : 131-135.
12. Bai H, Liu BW, Deng ZY, et al. Plasma very-low-density lipoprotein, low-density lipoprotein, and high-density lipoprotein oxidative modification induces procoagulant profiles in endogenous hypertriglyceridemia. Free Radie Biol Med, 2006 ; 40 (10) : 1796-1803.
13. Liu R, Saku K. Zhang B, et al. In vivo kinetics of oxidatively modified HDL. Biochem Med Metab Biol, 1993 ; 49 (3) : 392- 397.
14. Negre-Salvayre A, Dousset N, Ferretti G, et al. Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells. Free Radie Biol Med, 2006 ; 41 (7) : 1031-1040.
15. Chinese source
16. Perttu J, Lindsberg A,Grau J, et al. Inflammation and infections as risk factors for ischemic. Stroke, 2003 ; 34 (10) : 2518-2532.
17. Chinese source
18. Tylaska L, Boring L, Weng W, et al. CCR2 regulates the level of in vitro and at inflammatory sites and controls cell activation in response to alloantigen. Cytokine, 2002 ; 18 (4) : 184-190.
19. Banisadr G. Queraud L. Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J Neurochem, 2002 ; 81 (2) : 257-269.
20. Peterson KE, Errett JS, Wei T, et al. MCP-1 and CCR2 contribute to non-lymphocyte- mediated brain disease induced by Fr98 polytropic retrovirus infection in mice:role for astrocytes in retroviral neuropathogenesis. J Virol, 2004 ; 78 (12) : 6449-6458.
21. Mahad DJ, Ransohoff RM. The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Semin Immunol, 2003 ; 15 (1) : 23-32.
22. Jee Yh, Yoon WK, Okura Y, et al. Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats. Journal of Neuroimmunology, 2002 ; 128 (1) : 49-57.
23. Amanda M, Eric G, Elsa B, et al. Microglia activation after neonatal hypoxic-ischemia, Developmental Brain Research, 1995 ; 84 (2) : 245-252.